Judith YMN Engwegen

639 total citations
17 papers, 510 citations indexed

About

Judith YMN Engwegen is a scholar working on Spectroscopy, Molecular Biology and Cancer Research. According to data from OpenAlex, Judith YMN Engwegen has authored 17 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Spectroscopy, 9 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Judith YMN Engwegen's work include Advanced Proteomics Techniques and Applications (11 papers), Metabolomics and Mass Spectrometry Studies (7 papers) and Mass Spectrometry Techniques and Applications (6 papers). Judith YMN Engwegen is often cited by papers focused on Advanced Proteomics Techniques and Applications (11 papers), Metabolomics and Mass Spectrometry Studies (7 papers) and Mass Spectrometry Techniques and Applications (6 papers). Judith YMN Engwegen collaborates with scholars based in Netherlands, Germany and United States. Judith YMN Engwegen's co-authors include Jos H. Beijnen, Jan H.M. Schellens, Marie‐Christine W. Gast, Lodewyk F.A. Wessels, Wouter Meuleman, Annemieke Cats, Marcel Reinders, Niven Mehra, Emile E. Voest and John B.A.G. Haanen and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Trends in Pharmacological Sciences.

In The Last Decade

Judith YMN Engwegen

16 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Judith YMN Engwegen Netherlands 9 314 288 93 86 54 17 510
O. John Semmes United States 13 347 1.1× 315 1.1× 69 0.7× 61 0.7× 56 1.0× 24 564
Marie‐Christine W. Gast Netherlands 11 364 1.2× 317 1.1× 83 0.9× 85 1.0× 30 0.6× 14 552
Kelley C. McLean United States 7 298 0.9× 183 0.6× 58 0.6× 69 0.8× 21 0.4× 17 488
Sheeno Thyparambil United States 12 401 1.3× 126 0.4× 231 2.5× 90 1.0× 73 1.4× 41 614
Victor Yip United States 11 367 1.2× 217 0.8× 153 1.6× 52 0.6× 27 0.5× 14 647
Ruilian Xu China 13 218 0.7× 110 0.4× 113 1.2× 111 1.3× 48 0.9× 40 388
Jonathan Tolson Germany 7 212 0.7× 134 0.5× 79 0.8× 47 0.5× 226 4.2× 10 554
Mareike Elsner Germany 7 376 1.2× 346 1.2× 68 0.7× 64 0.7× 62 1.1× 7 567
Franziska Erlmeier Germany 12 304 1.0× 222 0.8× 197 2.1× 107 1.2× 132 2.4× 28 612
Maria Chan United States 10 258 0.8× 120 0.4× 57 0.6× 63 0.7× 42 0.8× 18 492

Countries citing papers authored by Judith YMN Engwegen

Since Specialization
Citations

This map shows the geographic impact of Judith YMN Engwegen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith YMN Engwegen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith YMN Engwegen more than expected).

Fields of papers citing papers by Judith YMN Engwegen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith YMN Engwegen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith YMN Engwegen. The network helps show where Judith YMN Engwegen may publish in the future.

Co-authorship network of co-authors of Judith YMN Engwegen

This figure shows the co-authorship network connecting the top 25 collaborators of Judith YMN Engwegen. A scholar is included among the top collaborators of Judith YMN Engwegen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith YMN Engwegen. Judith YMN Engwegen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Engwegen, Judith YMN & Nynke G L Jager. (2024). Dosing and Exposure of Vancomycin With Continuous Infusion: A Retrospective Study. Clinical Pharmacology & Therapeutics. 116(3). 665–669.
2.
Huiskes, Victor J B, et al.. (2022). The value of incorporating patient-consulted medication reconciliation in influencing drug-related actions in the outpatient rheumatology setting. BMC Health Services Research. 22(1). 995–995. 2 indexed citations
3.
Helgason, Helgi H., Judith YMN Engwegen, Marc Zapatka, et al.. (2010). Serum proteomics and disease-specific biomarkers of patients with advanced gastric cancer. Oncology Letters. 1(2). 327–333. 4 indexed citations
4.
Broek, Irene van den, Rolf W. Sparidans, Judith YMN Engwegen, et al.. (2010). Evaluation of human neutrophil peptide-1, -2 and -3 as serum markers for colorectal cancer. Cancer Biomarkers. 7(2). 109–115. 8 indexed citations
5.
Broek, Irene van den, Marie‐Christine W. Gast, Judith YMN Engwegen, et al.. (2010). Serum Degradome Markers for the Detection of Breast Cancer. Journal of Proteome Research. 9(8). 3781–3788. 37 indexed citations
7.
Meuleman, Wouter, Judith YMN Engwegen, Marie‐Christine W. Gast, Lodewyk F.A. Wessels, & Marcel Reinders. (2009). Analysis of mass spectrometry data using sub-spectra. BMC Bioinformatics. 10(S1). S51–S51. 8 indexed citations
8.
Engwegen, Judith YMN, Jaco C. Knol, Connie R. Jiménez, et al.. (2008). Influence of variations in sample handling on SELDI‐TOF MS serum protein profiles for colorectal cancer. PROTEOMICS - CLINICAL APPLICATIONS. 2(6). 936–945. 23 indexed citations
9.
Engwegen, Judith YMN, Annemieke Cats, Marianne E. Smits, Jan H.M. Schellens, & Jos H. Beijnen. (2008). Improving Colorectal Cancer Management: The Potential of Proteomics. Biomarkers in Medicine. 2(3). 253–289. 5 indexed citations
10.
Meuleman, Wouter, Judith YMN Engwegen, Marie‐Christine W. Gast, et al.. (2008). Comparison of normalisation methods for surface-enhanced laser desorption and ionisation (SELDI) time-of-flight (TOF) mass spectrometry data. BMC Bioinformatics. 9(1). 88–88. 42 indexed citations
11.
Gast, Marie‐Christine W., Judith YMN Engwegen, Jan H.M. Schellens, & Jos H. Beijnen. (2008). Comparing the old and new generation SELDI-TOF MS: implications for serum protein profiling. BMC Medical Genomics. 1(1). 4–4. 4 indexed citations
12.
Engwegen, Judith YMN, Annekatrien Depla, Marianne E. Smits, et al.. (2008). Detection of Colorectal Cancer by Serum and Tissue Protein Profiling: A Prospective Study in a Population at Risk. Biomarker Insights. 3. BMI.S790–BMI.S790. 15 indexed citations
13.
Engwegen, Judith YMN, Niven Mehra, John B.A.G. Haanen, et al.. (2007). Validation of SELDI-TOF MS serum protein profiles for renal cell carcinoma in new populations. Laboratory Investigation. 87(2). 161–172. 40 indexed citations
14.
Helgason, Helgi H., Judith YMN Engwegen, Annemieke Cats, et al.. (2007). Serum proteomic profiling of advanced gastric cancer and identification of proteomic changes following response to epirubicin, cisplatin and capecitabine chemotherapy as diagnostic and predictive biomarkers. Journal of Clinical Oncology. 25(18_suppl). 4537–4537. 1 indexed citations
16.
Engwegen, Judith YMN, Marie‐Christine W. Gast, Jan H.M. Schellens, & Jos H. Beijnen. (2006). Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry. Trends in Pharmacological Sciences. 27(5). 251–259. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026